Mednet Logo
CommunityHematology

How would you manage a patient with PV or ET who is experiencing breakthrough thrombosis?

For example, a patient on cytoreductive therapy and aspirin BID, but suffers an arterial event, or a patient who is already on therapeutic anticoagulation and has a recurrent VTE?
2 Answers
Mednet Member
Mednet MemberInvited Expert
Hematology · Johns Hopkins University
Answered on

The first question I would ask in this clinical situation is, "does the patient have PV or ET?"; a patient cannot have both. Unfortunately, I encounter this situation too often in my clinical practice. There appears to be a curious but dangerous belief in the medical community that ET is a more sero...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Hematology · University of Minnestoa
Answered on

Regardless of the underlying condition, such as either ET or PV in this example, my approach is similar to that described by Dr. Sam Schulman in this excellent review in the Blood "How I Treat Series" on recurrent VTE.

The primary question I think of is, "Why did prophylaxis fail and can I use this i...

Join for free or sign in to see the full answer